Av Therapeutics Private Limited - Company Profile

It is a healthcare private limited company based in Chennai, Tamil Nadu, India, established in 2013.
2013 Chennai, Tamil Nadu, India Struck Off
Last Updated:
Access Report
About Av Therapeutics Private Limited

Av Therapeutics Private Limited, a struck off private limited company, was established on 14 October 2013 in Chennai, Tamil Nadu, India. Engaging in medical & surgical equipment within the healthcare sector, it holds CIN: U33110TN2013PTC093304. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Thavasidevar Kurumbadevar Periyakaruppa Devar Asokan (Managing Director), Asokan Thilagavani (Director), Kadermeera Nallamohamed (Director). Past directors included Thavasidevar Kurumbadevar Periyakaruppa Devar Asokan, Arunachalam Esakkiappan. It is based at No - 1, Vaikkam Veerar Street East Tambaram, Chennai, Tamil Nadu, 600059.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33110TN2013PTC093304

  • Registration Number

    093304

  • Incorporation Date

    14 October 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 4 Months
Company report

Av Therapeutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Av Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Av Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Thavasidevar Kurumbadevar Periyakaruppa Devar Asokan Managing Director 14 Oct 2013 Current
Asokan Thilagavani Director 14 Oct 2013 Current
Kadermeera Nallamohamed Director 14 Oct 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 Oct 2013 Past
Pramod Abcsdd Director 18 Oct 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Av Therapeutics.

Enhance accessibility to Av Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Av Therapeutics revenue growth over time
Av Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Av Therapeutics?

Unlock access to Av Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Av Therapeutics?

Unlock and access historical data on people associated with Av Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Av Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Av Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Av Therapeutics
Recent Activity within the Organization
  • Director Appointment

    The activity Thavasidevar Kurumbadevar Periyakaruppa Devar Asokan was appointed as a Managing Director was appointed as a Managing Director on 14 Oct 2013 & has been associated with this company since 12 years 4 months . was completed.

  • Director Appointment

    Asokan Thilagavani was appointed as a Director was appointed as a Director on 14 Oct 2013 & has been associated with this company since 12 years 4 months . was recorded as a recent event.

  • Director Appointment

    Progress on Kadermeera Nallamohamed was appointed as a Director was appointed as a Director on 14 Oct 2013 & has been associated with this company since 12 years 4 months . was documented.

  • Company Incorporation

    Progress on Av Therapeutics Private Limited was registered on 14 Oct 2013 with Roc Chennai & aged 12 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Av Therapeutics Private Limited?

The CIN of Av Therapeutics Private Limited is U33110TN2013PTC093304.

Where is Av Therapeutics Private Limited headquartered?

Av Therapeutics Private Limited is headquartered at No - 1, Vaikkam Veerar Street East Tambaram, Chennai, Tamil Nadu, 600059.

When was Av Therapeutics Private Limited incorporated?

Av Therapeutics Private Limited was incorporated on 14 October 2013.

Who are the current directors of Av Therapeutics Private Limited?

The current directors of Av Therapeutics Private Limited are

What is the primary industry of Av Therapeutics Private Limited?

The primary industry of Av Therapeutics Private Limited is Healthcare.

Is Av Therapeutics Private Limited a listed company?

Av Therapeutics Private Limited is unlisted.

What is the capital structure of Av Therapeutics Private Limited?

The authorized capital of Av Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available